Rescue of alveolar wall liquid secretion blocks fatal lung injury due to influenza-staphylococcal coinfection
Stephanie Tang, … , Jahar Bhattacharya, Jaime L. Hook
Stephanie Tang, … , Jahar Bhattacharya, Jaime L. Hook
Published August 15, 2023
Citation Information: J Clin Invest. 2023;133(19):e163402. https://doi.org/10.1172/JCI163402.
View: Text | PDF
Research Article Pulmonology

Rescue of alveolar wall liquid secretion blocks fatal lung injury due to influenza-staphylococcal coinfection

Abstract

Secondary lung infection by inhaled Staphylococcus aureus (SA) is a common and lethal event for individuals infected with influenza A virus (IAV). How IAV disrupts host defense to promote SA infection in lung alveoli, where fatal lung injury occurs, is not known. We addressed this issue using real-time determinations of alveolar responses to IAV in live, intact, perfused lungs. Our findings show that IAV infection blocked defensive alveolar wall liquid (AWL) secretion and induced airspace liquid absorption, thereby reversing normal alveolar liquid dynamics and inhibiting alveolar clearance of inhaled SA. Loss of AWL secretion resulted from inhibition of the cystic fibrosis transmembrane conductance regulator (CFTR) ion channel in the alveolar epithelium, and airspace liquid absorption was caused by stimulation of the alveolar epithelial Na+ channel (ENaC). Loss of AWL secretion promoted alveolar stabilization of inhaled SA, but rescue of AWL secretion protected against alveolar SA stabilization and fatal SA-induced lung injury in IAV-infected mice. These findings reveal a central role for AWL secretion in alveolar defense against inhaled SA and identify AWL inhibition as a critical mechanism of IAV lung pathogenesis. AWL rescue may represent a new therapeutic approach for IAV-SA coinfection.

Authors

Stephanie Tang, Ana Cassandra De Jesus, Deebly Chavez, Sayahi Suthakaran, Sarah K.L. Moore, Keshon Suthakaran, Sonya Homami, Raveen Rathnasinghe, Alison J. May, Michael Schotsaert, Clemente J. Britto, Jahar Bhattacharya, Jaime L. Hook

×

Figure 8

IAV augments the lung pathogenesis of SAGFP.

Options: View larger image (or click on image) Download as PowerPoint
IAV augments the lung pathogenesis of SAGFP. Experimental design (A) for...
Experimental design (A) for group data (B–E) indicates timing of intranasal instillations, survival (B) and breathing score (C) assessments, and BAL fluid collection for quantifications of total protein (D) and leukocytes (E). All mice were given a series of 2 instillations as indicated. Breathing scores (C) were imputed for non-surviving mice using their last observed value. Squares (C) and bars (D and E) indicate mean ± SEM; circles (D and E) indicate n and each represent data from 1 mouse; *P < 0.05 vs. black line by log rank (B) or 2-tailed t test (C) or as indicated by ANOVA with post hoc Tukey testing (D and E). BAL contents of protein (D) and leukocytes (E) were quantified using the same fluid specimens.